Modelling that shaped the early COVID-19 pandemic response in the UK | Zendy

Ellen BrooksPollock | Zendy; León Da | Zendy; Thibaut Jombart | Zendy; Lorenzo Pellis | Zendy

AI Assistant Blog Pricing

Home ZAIA Blog

Open Access

Modelling that shaped the early COVID-19 pandemic response in the UK

Author(s) -

Ellen BrooksPollock,

León Da,

Thibaut Jombart,

Lorenzo Pellis

Publication year - 2021

Publication title -

philosophical transactions of the royal society b biological sciences

Language(s) - English

Resource type - Journals

SCImago Journal Rank - 2.753

H-Index - 272

eISSN - 1471-2970

pISSN - 0962-8436

DOI - 10.1098/rstb.2021.0001

Subject(s) - pandemic , transparency (behavior) , covid-19 , government (linguistics) , political science , scientific evidence , publishing , infectious disease (medical specialty) , emergency response , public relations , medicine , disease , medical emergency , law , pathology , linguistics , philosophy , epistemology

Infectious disease modelling has played an integral part of the scientific evidence used to guide the response to the COVID-19 pandemic. In the UK, modelling evidence used for policy is reported to the Scientific Advisory Group for Emergencies (SAGE) modelling subgroup, SPI-M-O (Scientific Pandemic Influenza Group on Modelling-Operational). This Special Issue contains 20 articles detailing evidence that underpinned advice to the UK government during the SARS-CoV-2 pandemic in the UK between January 2020 and July 2020. Here, we introduce the UK scientific advisory system and how it operates in practice, and discuss how infectious disease modelling can be useful in policy making. We examine the drawbacks of current publishing practices and academic credit and highlight the importance of transparency and reproducibility during an epidemic emergency. This article is part of the theme issue ‘Modelling that shaped the early COVID-19 pandemic response in the UK’.

The content you want is available to Zendy users.

Already have an account? Click here to sign in.

Having issues? You can contact us here

Accelerating Research